When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Marc Semigran M.D.
Marc Semigran, M.D., is the chief medical officer for MyoKardia. Previously, he led the Massachusetts General Hospital Heart Failure and Cardiac Transplant Program as section head and medical director. Dr. Semigran was a member of the internal medicine and cardiology staff of Massachusetts General for more than 25 years and is an associate professor at Harvard Medical School, where he also earned his A.B., A.M. and M.D. degrees.
More GEN Content From This Contributor
- GEN Exclusives: Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
- Feature Articles: Why Cardiology Is the Next Frontier for Precision Medicine